Dupilumab in Severe Asthma: A Real-Life Cohort in France

被引：0
|
作者：
Dupin, C. [1 ,2 ]
Guilleminault, L. [3 ]
Bonniaud, P. [4 ]
Gamez, A. [5 ]
Leroyer, C. [6 ]
Mahay, G. [7 ]
De Blay, F. [8 ]
Fry, S. [9 ]
Le Bourdelles, G. [10 ]
Proust, A. [11 ]
Rosencher, L. [12 ]
Belhadi, D. [13 ]
Berger, P. [14 ]
Dider, A. [3 ]
Bourdin, A. [15 ]
Chenivesse, C. [9 ]
Garcia, G. [16 ]
Couffignal, C. [13 ]
Taille, C. [1 ,2 ]
机构：
[1] Hop Bichat Claude Bernard, Serv Pneumol, Paris, France
[2] Hop Bichat Claude Bernard, Ctr Reference Constitutif Malad Pulm Rares, Paris, France
[3] Hop Larrey, Pole Voies Resp, Toulouse, France
[4] CHU Bourgogne, Serv Pneumol & Soins Intens Resp, Dijon, France
[5] CHU Montpellier, De & 769 Partement Pneumol & Addictol, Ho & 770 Pital Arnaud de Villeneuve, Montpellier, France
[6] Hop La Cavale Blanche, Dept Med Interne & Pneumol, Brest, France
[7] CHU Rouen, Serv Pneumol Oncol Thorac & Soins Intens Resp Pne, Rouen, France
[8] CHU Strasbourg, Dept Pathol Thorac, Strasbourg, France
[9] CHU Lille, Serv Pneumol & Immunoallergol, Lille, France
[10] Hop Foch, Serv Pneumol, Suresnes, France
[11] CHU Nimes, Serv Pneumol, Npimes, France
[12] Hop Tenon, Sdept Pneumol & Reanimat Resp, Unite Fonct Oncol Thorac, Paris, France
[13] Hop Bichat Claude Bernard, Unite Rech Clin, Paris, France
[14] CHU Bordeaux, Serv Pneumol, Bordeaux, France
[15] CHU Montpellier, Ho & 770 Pital Arnaud de Villeneuve, De & 769 Partement Pneumol & Addictol, Paris, France
[16] Hop Bicetre, AP HP, Serv Pneumol, Le Kremlin Bicetre, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1267
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
    Pelaia, Corrado
    Benfante, Alida
    Busceti, Maria Teresa
    Caiaffa, Maria Filomena
    Campisi, Raffaele
    Carpagnano, Giovanna Elisiana
    Crimi, Nunzio
    D'Amato, Maria
    Barbaro, Maria Pia Foschino
    Maglio, Angelantonio
    Minenna, Elena
    Nolasco, Santi
    Paglino, Giuseppe
    Papia, Francesco
    Pelaia, Girolamo
    Portacci, Andrea
    Ricciardi, Luisa
    Scichilone, Nicola
    Scioscia, Giulia
    Triggiani, Massimo
    Valenti, Giuseppe
    Vatrella, Alessandro
    Crimi, Claudia
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
    Pelaia, Corrado
    Benfante, Alida
    Busceti, Maria Teresa
    Caiaffa, Maria Filomena
    Campisi, Raffaele
    Carpagnano, Giovanna Elisiana
    Crimi, Nunzio
    D'Amato, Maria
    Barbaro, Maria Pia Foschino
    Maglio, Angelantonio
    Minenna, Elena
    Nolasco, Santi
    Paglino, Giuseppe
    Papia, Francesco
    Pelaia, Girolamo
    Portacci, Andrea
    Ricciardi, Luisa
    Scichilone, Nicola
    Scioscia, Giulia
    Triggiani, Massimo
    Valenti, Giuseppe
    Vatrella, Alessandro
    Crimi, Claudia
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [43] Real-life cost-effectiveness of benralizumab in patients with severe asthma
    Padilla-Galo, A.
    Garcia-Ruiz, A. J.
    Levy Abitbol, R. Ch.
    Olveira, C.
    Rivas-Ruiz, F.
    Garcia-Agua Soler, N.
    Perez Morales, M.
    Valencia Azcona, B.
    Tortajada-Goitia, B.
    Moya-Carmona, I.
    Levy-Naon, A.
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [44] Real-life Cretan asthma registry focused on severe asthma: On behalf of 'The Cretan registry of the use of Biologics in Severe Asthma'
    Antoniou, Katerina M.
    Bolaki, Maria
    Karagiannis, Konstantinos
    Trachalaki, Athina
    Ierodiakonou, Despo
    Stamatopoulou, Vagia
    Chatzinikolaou, Charito
    Mastrodimou, Semeli
    Stamataki, Evangelia
    Pitsidianakis, George
    Lambiri, Irini
    Mitrouska, Ioanna
    Spandidos, Demetrios A.
    Tzanakis, Nikolaos
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (05)
  • [45] Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma
    Chaudhuri, Rekha
    Heaney, Liam G.
    Gallagher, Nicola
    Brightling, Christopher E.
    Menzies-Gow, Andrew N.
    Mansur, Adel H.
    Niven, Robert
    Cowan, Douglas C.
    Lee, Wai-ting N.
    McSharry, Charles
    Shepherd, Malcolm
    Patterson, Christopher C.
    Yang, Jieqiong F.
    Thomson, Neil C.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [46] Dupilumab in improving control of severe asthma in real life. Report of two cases
    Leru, P.
    Anton, V.
    ALLERGY, 2023, 78
  • [47] Efficacy of dupilumab in real-life settings: a STROBE study
    Gal, A.
    Gravier-Dumonceau, R.
    Penicaud, M.
    Ebode, D.
    Radulesco, T.
    Michel, J.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (09) : 4781 - 4788
  • [48] Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium
    Verhamme, Katia M. C.
    Lucet, Catherine
    Van Meerhaeghe, Alain
    Brusselle, Guy G. O.
    Lambert, Marie-Laurence
    ERJ OPEN RESEARCH, 2019, 5 (04)
  • [49] Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study
    De Corso, Eugenio
    Montuori, Claudio
    Baroni, Silvia
    Mastrapasqua, Rodolfo F.
    Porru, Davide P.
    D'Auria, Leandro M.
    D'Agostino, Giuseppe
    Penazzi, Daniele
    De Maio, Gabriele
    Onori, Maria E.
    Sarlo, Francesca
    Corbo, Marco
    Galli, Jacopo
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (03) : 1449 - 1456
  • [50] Effectiveness and safety of dupilumab in adults with moderate and severe atopic dermatitis in Colombia: Real-life experience
    Londono, Julian
    Perez, Lucia
    Moreno, Sergio
    Chapman, Edgardo
    Garcia, Maria Beatriz
    Celis, Ana Maria
    Munoz, Maria Angelica
    Castillo, David
    Sanchez, Jorge
    Arevalo, Yaicith
    Lozano, Ana
    Alvis-Zakzuk, Nelson J.
    Munoz, Cesar
    Botero, Laura
    Beltran, Catalina
    Garcia, Elizabeth
    WORLD ALLERGY ORGANIZATION JOURNAL, 2023, 16 (04):
12345